Diabetic embryopathy: A developmental perspective from fertilization to adulthood

Molecular Syndromology

Volumn 4, Issue 1-2, 2013, Pages 74-86

  Castori, M ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Blastogenesis; Diabetes mellitus; DOHeD; Epigenetics; Spontaneous abortion; VACTERL

Indexed keywords

GLYCOSYLATED HEMOGLOBIN;

ADULTHOOD; ANUS ATRESIA; ARTICLE; BIRTH DEFECT; CAUDAL REGRESSION SYNDROME; CLEFT LIP; CLEFT PALATE; CONGENITAL HEART MALFORMATION; EARLY DIAGNOSIS; EMBRYO DEVELOPMENT; EMBRYOPATHY; EMBRYOTOXICITY; FERTILIZATION; FETUS ECHOGRAPHY; FETUS MALFORMATION; GLUCOSE INTOLERANCE; HEMIFACIAL MICROSOMIA; HEMOGLOBIN BLOOD LEVEL; HOLOPROSENCEPHALY; HUMAN; HYDROCEPHALUS; HYPERTROPHIC CARDIOMYOPATHY; LIMB DEFECT; MATERNAL DIABETES MELLITUS; MICROTIA; NEURAL TUBE DEFECT; NEWBORN DEATH; PERINATAL DEATH; PLACENTA INSUFFICIENCY; PRIORITY JOURNAL; PROGENY; SECOND TRIMESTER ABORTION; SEPTOOPTIC DYSPLASIA; SIRENOMELIA; SKELETON MALFORMATION; SPONTANEOUS ABORTION; TERATOGENESIS; THYMUS APLASIA; VITAMIN SUPPLEMENTATION; ADULT DISEASE; DIABETES MELLITUS; DIABETIC EMBRYOPATHY; EPIGENETICS; FETUS RISK; GENETIC RISK; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE TRANSFORMATION; MACROSOMIA; MOTHER FETUS RELATIONSHIP; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PLEIOTROPY; PREGNANT WOMAN;

EID: 84874090453     PISSN: 16618769     EISSN: 16618777     Source Type: Journal    
DOI: 10.1159/000345205     Document Type: Article

References (102)

1. Auerbach R: Analysis of the developmental effects of a lethal mutation in the house mouse. J Exp Zool 127: 305-329 (1954).
2. Balsells M, García-Patterson A, Gich I, Corcoy R: Maternal and fetal outcome in women with type 2 versus type 1 diabetes mellitus: A systematic review and metaanalysis. J Clin Endocrinol Metab 94: 4284-4291 (2009).
3. Balsells M, García-Patterson A, Gich I, Corcoy R: Major congenital malformations in women with gestational diabetes mellitus: A systematic review and meta-analysis. Diabetes Metab Res Rev 28: 252-257 (2012).
4. Bánhidy F, Acs N, Puhó EH, Czeizel AE: Congenital abnormalities in the offspring of pregnant women with type 1, type 2 and gestational diabetes mellitus: A populationbased case-control study. Congenit Anom (Kyoto) 50: 115-121 (2010).
5. Barker DJ: The developmental origins of adult disease. J Am Coll Nutr 23 Suppl 6: 588S-595S (2004).
6. Barr M Jr, Hanson JW, Currey K, Sharp S, Toriello H, et al: Holoprosencephaly in infants of diabetic mothers. J Pediatr 102: 565-568 (1983).
7. Becerra JE, Khoury MJ, Cordero JF, Erickson JD: Diabetes mellitus during pregnancy and the risks for specific birth defects: A populationbased case-control study. Pediatrics 85: 1-9 (1990).
8. Boulot P, Chabbert-Buffet N, d'Ercole C, Floriot M, Fontaine P, et al: French multicentric survey of outcome of pregnancy in women with pregestational diabetes. Diabetes Care 26: 2990-2993 (2003).
9. Boutte P, Valla JS, Lambert JC, Tordjman C, Berard E, Mariani R: The Vater association in a newborn infant of a diabetic mother [in French]. Pediatrie 40: 219-222 (1985).
10. Brownlee M: Biochemistry and molecular cell biology of diabetic complications. Nature 414: 813-820 (2001).
11. Carmichael SL, Rasmussen SA, Shaw GM: Prepregnancy obesity: A complex risk factor for selected birth defects. Birth Defects Res A Clin Mol Teratol 88: 804-810 (2010).
12. Castori M, Rinaldi R, Capocaccia P, Roggini M, Grammatico P: VACTERL association and maternal diabetes: A possible causal relationship? Birth Defects Res A Clin Mol Teratol 82: 169-172 (2008).
13. Castori M, Silvestri E, Cappellacci S, Binni F, Sforzolini GS, Grammatico P: Sirenomelia and VACTERL association in the offspring of a woman with diabetes. Am J Med Genet A 152A:1803-1807 (2010).
14. Cederberg J, Simán CM, Eriksson UJ: Combined treatment with vitamin E and vitamin C decreases oxidative stress and improves fetal outcome in experimental diabetic pregnancy. Pediatr Res 49: 755-762 (2001).
15. Chen CP, Chen CY, Lin CY, Shaw SW, Wang W, Tzen CY: Prenatal diagnosis of concomitant alobar holoprosencephaly and caudal regression syndrome associated with maternal diabetes. Prenat Diagn 25: 264-266 (2005).
16. Clausen TD, Mathiesen E, Ekbom P, Hellmuth E, Mandrup-Poulsen T, Damm P: Poor pregnancy outcome in women with type 2 diabetes. Diabetes Care 28: 323-328 (2005).
17. Clausen TD, Mathiesen ER, Hansen T, Pedersen O, Jensen DM, et al: High prevalence of type 2 diabetes and pre-diabetes in adult offspring of women with gestational diabetes mellitus or type 1 diabetes: the role of intrauterine hyperglycemia. Diabetes Care 31: 340-346 (2008).
18. Comess LJ, Bennett PH, Burch TA, Miller M: Congenital anomalies and diabetes in the Prima Indians of Arizona. Diabetes 18: 471-477 (1969).
19. Correa A, Gilboa SM, Besser LM, Botto LD, Moore CA, et al: Diabetes mellitus and birth defects. Am J Obstet Gynecol 199: 237.e1-9 (2008).
20. Crespi BJ: The emergence of human-evolutionary medical genomics. Evol Appl 4: 292-314 (2011).
21. Croen LA, Shaw GM, Lammer EJ: Risk factors for cytogenetically normal holoprosencephaly in California: A population-based casecontrol study. Am J Med Genet 90: 320-325 (2000).
22. Damasceno DC, Volpato GT, de Mattos Paranhos Calderon I, Cunha Rudge MV: Oxidative stress and diabetes in pregnant rats. Anim Reprod Sci 72: 235-244 (2002).
23. Davis EM, Peck JD, Thompson D, Wild RA, Langlois P: Maternal diabetes and renal agenesis/dysgenesis. Birth Defects Res A Clin Mol Teratol 88: 722-727 (2010).
24. De Hertogh R, Vanderheyden I, Pampfer S, Robin D, Dufrasne E, Delcourt J: Stimulatory and inhibitory effects of glucose and insulin on rat blastocyst development in vitro. Diabetes 40: 641-647 (1991).
25. Dentici ML, Placidi S, Francalanci P, Capolino R, Rinelli G, et al: Association of DiGeorge anomaly and caudal dysplasia sequence in a neonate born to a diabetic mother. Cardiol Young 6: 1-4 (2012).
26. Deuchar EM: Embryonic malformations in rats, resulting from maternal diabetes: preliminary observations. J Embryol Exp Morphol 41: 93-99 (1977).
27. de Valk HW, van Nieuwaal NH, Visser GH: Pregnancy outcome in type 2 diabetes mellitus: A retrospective analysis from the Netherlands. Rev Diabet Stud 3: 134-142 (2006).
28. Digilio MC, Marino B, Formigari R, Giannotti A: Maternal diabetes causing DiGeorge anomaly and renal agenesis. Am J Med Genet 55: 513-514 (1995).
29. Donat JF: Septo-optic dysplasia in an infant of a diabetic mother. Arch Neurol 38: 590-591 (1981).
30. Driscoll SG: The pathology of pregnancy complicated by diabetes mellitus. Med Clin North Am 49: 1053-1067 (1965).
31. Dudley DJ: Diabetic-associated stillbirth: incidence, pathophysiology, and prevention. Obstet Gynecol Clin North Am 34: 293-307 (2007).
32. Duncan PA, Shapiro LR, Klein RM: Sacrococcygeal dysgenesis association. Am J Med Genet 41: 153-161 (1991).
33. el-Hage S, Singh SM: Temporal expression of genes encoding free radical-metabolizing enzymes is associated with higher mRNA levels during in utero development in mice. Dev Genet 11: 149-159 (1990).
34. Eriksson UJ: Diabetes in pregnancy: effects on post-implantation embryos. Isr J Med Sci 27: 478-486 (1991).
35. Eriksson UJ, Bone AJ, Turnbull DM, Baird JD: Timed interruption of insulin therapy in diabetic BB/E rat pregnancy: effect on maternal metabolism and fetal outcome. Acta Endocrinol (Copenh) 120: 800-810 (1989).
36. Evers IM, de Valk HW, Visser GH: Risk of complications of pregnancy in women with type 1 diabetes: nationwide prospective study in the Netherlands. BMJ 328: 915 (2004).
37. Ewart-Toland A, Yankowitz J, Winder A, Imagire R, Cox VA, et al: Oculoauriculovertebral abnormalities in children of diabetic mothers. Am J Med Genet 90: 303-309 (2000).
38. Fernández-Morera JL, Rodríguez-Rodero S, Menéndez-Torre E, Fraga MF: The possible role of epigenetics in gestational diabetes: cause, consequence, or both. Obstet Gynecol Int 2010: 605163 (2010).
39. Fine EL, Horal M, Chang TI, Fortin G, Loeken MR: Evidence that elevated glucose causes altered gene expression, apoptosis, and neural tube defects in a mouse model of diabetic pregnancy. Diabetes 48: 2454-2462 (1999).
40. Frías JL, Frías JP, Frías PA, Martínez- Frías ML: Infrequently studied congenital anomalies as clues to the diagnosis of maternal diabetes mellitus. Am J Med Genet A 143A:2904-2909 (2007).
41. Gäreskog M, Eriksson UJ, Wentzel P: Combined supplementation of folic acid and vitamin E diminishes diabetes-induced embryotoxicity in rats. Birth Defects Res A Clin Mol Teratol 76: 483-490 (2006).
42. Gosseye S, Golaire MC, Verellen G, Van Lierde M, Claus D: Association of bilateral renal agenesis and Di George syndrome in an infant of a diabetic mother. Helv Paediatr Acta 37: 471-474 (1982).
43. Greene MF, Hare JW, Cloherty JP, Benacerraf BR, Soeldner JS: First-trimester hemoglobin A1 and risk for major malformation and spontaneous abortion in diabetic pregnancy. Teratology 39: 225-231 (1989).
44. Gripp KW, Barr M Jr, Anadiotis G, McDonald-McGinn DM, Zderic SA, Zackai EH: Aphallia as part of urorectal septum malformation sequence in an infant of a diabetic mother. Am J Med Genet 82: 363-367 (1999).
45. Hall BD: VATER/VACTERL association, in Cassidy SB, Allanson JE (eds): Management of Genetic Syndromes, ed 3, pp 871-880 (Wiley-Bleckwell, Hoboken 2010).
46. Hanson U, Persson B: Outcome of pregnancies complicated by type 1 insulin-dependent diabetes in Sweden: acute pregnancy complications, neonatal mortality and morbidity. Am J Perinatol 10: 330-333 (1993).
47. Hod M, Star S, Passonneau JV, Unterman TG, Freinkel N: Effect of hyperglycemia on sorbitol and myo-inositol content of cultured rat conceptus: failure of aldose reductase inhibitors to modify myo-inositol depletion and dysmorphogenesis. Biochem Biophys Res Commun 140: 974-980 (1986).
48. Horii KI, Watanabe GI, Ingalls TH: Experimental diabetes in pregnant mice. Prevention of congenital malformations in offspring by insulin. Diabetes 15: 194-204 (1966).
49. Hunter ES 3rd, Sadler TW: Fuel-mediated teratogenesis: biochemical effects of hypoglycemia during neurulation in mouse embryos in vitro. Am J Physiol 257:E269-276 (1989).
50. Ishibashi M, Akazawa S, Sakamaki H, Matsumoto K, Yamasaki H, et al: Oxygen-induced embryopathy and the significance of glutathione-dependent antioxidant system in the rat embryo during early organogenesis. Free Radic Biol Med 22: 447-454 (1997).
51. Jain SK, McVie R, Duett J, Herbst JJ: Erythrocyte membrane lipid peroxidation and glycosylated hemoglobin in diabetes. Diabetes 38: 1539-1543 (1989).
52. James AW, Culver K, Hall B, Golabi M: Bifid tongue: A rare feature associated with infants of diabetic mother syndrome. Am J Med Genet A 143A:2035-2039 (2007).
53. Jensen DM, Damm P, Moelsted-Pedersen L, Ovesen P, Westergaard JG, et al: Outcomes in type 1 diabetic pregnancies: A nationwide, population-based study. Diabetes Care 27: 2819-2823 (2004).
54. Johnson JP, Carey JC, Gooch WM 3rd, Petersen J, Beattie JF: Femoral hypoplasia-unusual facies syndrome in infants of diabetic mothers. J Pediatr 102: 866-872 (1983).
55. Joss-Moore LA, Lane RH: The developmental origins of adult disease. Curr Opin Pediatr 21: 230-234 (2009).
56. Kalter H: Diabetes and spontaneous abortion: A historical review. Am J Obstet Gynecol 156: 1243-1253 (1987).
57. Kalter H: Case reports of malformations associated with maternal diabetes: history and critique. Clin Genet 43: 174-179 (1993).
58. Kitzmiller JL, Buchanan TA, Kjos S, Combs CA, Ratner RE: Pre-conception care of diabetes, congenital malformations, and spontaneous abortions. Diabetes Care 19: 514-541 (1996).
59. Kitzmiller JL, Wallerstein R, Correa A, Kwan S: Preconception care for women with diabetes and prevention of major congenital malformations. Birth Defects Res A Clin Mol Teratol 88: 791-803 (2010).
60. Kucera J: Rate and type of congenital anomalies among offspring of diabetic women. J Reprod Med 7: 73-82 (1971).
61. Kusters DM, Lahsinoui HH, van de Post JA, Wiegman A, Wijburg FA, et al: Statin use during pregnancy: A systematic review and meta-analysis. Expert Rev Cardiovasc Ther 10: 363-378 (2012).
62. Lauenborg J, Mathiesen E, Ovesen P, Westergaard JG, Ekbom P, et al: Audit on stillbirths in women with pregestational type 1 diabetes. Diabetes Care 26: 1385-1389 (2003).
63. Li R, Chase M, Jung SK, Smith PJ, Loeken MR: Hypoxic stress in diabetic pregnancy contributes to impaired embryo gene expression and defective development by inducing oxidative stress. Am J Physiol Endocrinol Metab 289:E591-E599 (2005).
64. Lisowski LA, Verheijen PM, Copel JA, Kleinman CS, Wassink S, et al: Congenital heart disease in pregnancies complicated by maternal diabetes mellitus. An international clinical collaboration, literature review, and metaanalysis. Herz 35: 19-26 (2010).
65. Loffredo CA, Wilson PD, Ferencz C: Maternal diabetes: an independent risk factor for major cardiovascular malformations with increased mortality of affected infants. Teratology 64: 98-106 (2001).
66. Macintosh MC, Fleming KM, Bailey JA, Doyle P, Modder J, et al: Perinatal mortality and congenital anomalies in babies of women with type 1 or type 2 diabetes in England, Wales, and Northern Ireland: population based study. BMJ 333: 177 (2006).
67. Martínez-Frías ML: Epidemiological analysis of outcomes of pregnancy in diabetic mothers: identification of the most characteristic and most frequent congenital anomalies. Am J Med Genet 51: 108-113 (1994).
68. Melamed N, Hod M: Perinatal mortality in pregestational diabetes. Int J Gynaecol Obstet 104 Suppl 1:S20-S24 (2009).
69. Miller EA, Rasmussen SA, Siega-Riz AM, Frías JL, Honein MA; National Birth Defects Prevention Study: Risk factors for non-syndromic holoprosencephaly in the National Birth Defects Prevention Study. Am J Med Genet C Semin Med Genet 154C:62-72 (2010).
70. Miller JF, Williamson E, Glue J, Gordon YB, Grudzinskas JG, Sykes A: Fetal loss after implantation. A prospective study. Lancet 2: 554-556 (1980).
71. Mills JL, Simpson JL, Driscoll SG, Jovanovic-Peterson L, Van Allen M, et al: Incidence of spontaneous abortion among normal women and insulin-dependent diabetic women whose pregnancies were identified within 21 days of conception. N Engl J Med 319: 1617-1623 (1988).
72. Mimouni F, Miodovnik M, Siddiqi TA, Khoury J, Tsang RC: Perinatal asphyxia in infants of insulin-dependent diabetic mothers. J Pediatr 113: 345-353 (1988).
73. Novak RW, Robinson HB: Coincident DiGeorge anomaly and renal agenesis and its relation to maternal diabetes. Am J Med Genet 50: 311-312 (1994).
74. Opitz JM: Blastogenesis and the 'primary field' in human development. Birth Defects Orig Artic Ser 29: 3-37 (1993).
75. Opitz JM, Zanni G, Reynolds JF Jr, Gilbert-Barness E: Defects of blastogenesis. Am J Med Genet 115: 269-286 (2002).
76. Ornoy A, Zusman I: Embryotoxic effects of diabetes on pre-implantation embryos. Isr J Med Sci 27: 487-492 (1991).
77. Pampfer S, de Hertogh R, Vanderheyden I, Michiels B, Vercheval M: Decreased inner cell mass proportion in blastocysts from diabetic rats. Diabetes 39: 471-476 (1990).
78. Pani L, Horal M, Loeken MR: Polymorphic susceptibility to the molecular causes of neural tube defects during diabetic embryopathy. Diabetes 51: 2871-2874 (2002a).
79. Pani L, Horal M, Loeken MR: Rescue of neural tube defects in Pax-3-deficient embryos by p53 loss of function: implications for Pax-3-dependent development and tumorigenesis. Genes Dev 16: 676-680 (2002b).
80. Pedersen J, Mølsted-Pedersen LM: Congenital malformations: the possible role of diabetes care outside pregnancy. Ciba Found Symp 63: 265-271 (1978).
81. Phelan SA, Ito M, Loeken MR: Neural tube defects in embryos of diabetic mice: role of the Pax-3 gene and apoptosis. Diabetes 46: 1189-1197 (1997).
82. Platt MJ, Stanisstreet M, Casson IF, Howard CV, Walkinshaw S, et al: St Vincent's Declaration 10 years on: outcomes of diabetic pregnancies. Diabet Med 19: 216-220 (2002).
83. Polifka JE: Is there an embryopathy associated with first-trimester exposure to angiotensin-converting enzyme inhibitors and angiotensin receptor antagonists? A critical review of the evidence. Birth Defects Res A Clin Mol Teratol 94: 576-598 (2012).
84. Reece EA: Diabetes-induced birth defects: what do we know? What can we do? Curr Diab Rep 12: 24-32 (2012).
85. Reece EA, Homko CJ, Wu YK: Multifactorial basis of the syndrome of diabetic embryopathy. Teratology 54: 171-182 (1996).
86. Salbaum JM, Kappen C: Neural tube defect genes and maternal diabetes during pregnancy. Birth Defects Res A Clin Mol Teratol 88: 601-611 (2010).
87. Salbaum JM, Kappen C: Diabetic embryopathy: A role for the epigenome? Birth Defects Res A Clin Mol Teratol 91: 770-780 (2011).
88. Salbaum JM, Kappen C: Responses of the embryonic epigenome to maternal diabetes. Birth Defects Res A Clin Mol Teratol 94: 770-781 (2012).
89. Smoak IW, Sadler TW: Embryopathic effects of short-term exposure to hypoglycemia in mouse embryos in vitro. Am J Obstet Gynecol 163: 619-624 (1990).
90. Solomons NW: Developmental origins of health and disease: concepts, caveats, and consequences for public health nutrition. Nutr Rev 67 Suppl 1:S12-S16 (2009).
91. Sugimura Y, Murase T, Kobayashi K, Oyama K, Hayasaka S, et al: Alpha-lipoic acid reduces congenital malformations in the offspring of diabetic mice. Diabetes Metab Res Rev 25: 287-294 (2009).
92. Sussman I, Matschinsky FM: Diabetes affects sorbitol and myo-inositol levels of neuroectodermal tissue during embryogenesis in rat. Diabetes 37: 974-981 (1988).
93. Uriu-Hare JY, Stern JS, Keen CL: Influence of maternal dietary Zn intake on expression of diabetes-induced teratogenicity in rats. Diabetes 38: 1282-1290 (1989).
94. Valenzano M, Paoletti R, Rossi A, Farinini D, Garlaschi G, Fulcheri E: Sirenomelia. Pathological features, antenatal ultrasonographic clues, and a review of current embryogenic theories. Hum Reprod Update 5: 82-86 (1999).
95. Vaz SS, Chodirker B, Prasad C, Seabrook JA, Chudley AE, Prasad AN: Risk factors for nonsyndromic holoprosencephaly: A Manitoba case-control study. Am J Med Genet A 158A:751-758 (2012).
96. Wang R, Martínez-Frías ML, Graham JM Jr: Infants of diabetic mothers are at increased risk for the oculo-auriculo-vertebral sequence: A case-based and case-control approach. J Pediatr 141: 611-617 (2002).
97. Watanabe G, Ingalls TH: Congenital malformations in the offspring of alloxan-diabetic mice. Diabetes 12: 66-72 (1963).
98. White P: Pregnancy complicating diabetes, in Joslin EP, Root HF, White P, Marble A (eds): The Treatment of Diabetes Mellitus, pp 633-638 (Lea & Febiger, Philadelphia 1937).
99. Wilson TA, Blethen SL, Vallone A, Alenick DS, Nolan P, et al: DiGeorge anomaly with renal agenesis in infants of mothers with diabetes. Am J Med Genet 47: 1078-1082 (1993).
100. Yajnik CS: Nutrient-mediated teratogenesis and fuel-mediated teratogenesis: two pathways of intrauterine programming of diabetes. Int J Gynaecol Obstet 104 Suppl 1:S27-S31 (2009).
101. Yogev Y, Chen R, Ben-Haroush A, Hod M, Bar J: Maternal overweight and pregnancy outcome in women with Type-1 diabetes mellitus and different degrees of nephropathy. J Matern Fetal Neonatal Med 23: 999-1003 (2010).
102. Zabihi S, Loeken MR: Understanding diabetic teratogenesis: where are we now and where are we going? Birth Defects Res A Clin Mol Teratol 88: 779-790 (2010).